Following finalized regulations from the Florida Department of Health for the sale of edible cannabis products, Trulieve will introduce edibles in its medical cannabis dispensaries across the state.

The U.S. Food and Drug Administration has approved Epidiolex (cannabidiol) oral solution for the treatment of seizures associated with tuberous sclerosis complex, a genetic disorder characterized by growth of numerous noncancerous tumors.

BDS Analytics has launched adult-use and medical cannabis retail sales tracking in Massachusetts.

Coda Signature has released infused chocolate bars with expanded dosage options for medical patients.